Kingsley Leung
Chairman bij UNI-BIO SCIENCE GROUP LIMITED
Vermogen: 17 M $ op 31-03-2024
Profiel
Kingsley Leung is the founder of Great Bay Bio Holdings Ltd.
He currently holds multiple positions including Chairman at Uni-Bio Science Group Ltd., Director at Greater Bay Capital Ltd., Associate at The Hong Kong Institute of Directors, and Member at The Hong Kong Society of Financial Analysts.
Previously, he served as Vice Chairman-Pharmaceutical & Chemical Group at Federation of Hong Kong Industries, Manager-Business Development at ASLAN Pharmaceuticals Pte Ltd., and Vice President at Young Innovation & Development Alliance.
Mr. Leung obtained his graduate degree from the University of Oxford in 2009 and his undergraduate degree from Imperial College London in 2008.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
UNI-BIO SCIENCE GROUP LTD.
26.79% | 30-06-2023 | 1 650 971 464 ( 26.79% ) | 17 M $ | 31-03-2024 |
Actieve functies van Kingsley Leung
Bedrijven | Functie | Begin |
---|---|---|
UNI-BIO SCIENCE GROUP LIMITED | Chairman | 13-01-2017 |
The Hong Kong Society of Financial Analysts | Corporate Officer/Principal | - |
The Hong Kong Institute of Directors
The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
Greater Bay Capital Ltd.
Greater Bay Capital Ltd. Financial ConglomeratesFinance Greater Bay Capital Ltd. operates as an investment holding company. The company is headquartered in British Virgin Islands. | Director/Board Member | - |
Great Bay Bio Holdings Ltd.
Great Bay Bio Holdings Ltd. Packaged SoftwareTechnology Services Great Bay Bio Holdings Ltd. is a high-tech enterprise based in China that specializes in applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing. The Chinese company aims to solve numerous pain-points of the biopharmaceutical industry, including high failure rates, long development timelines, and high costs. Great Bay Bio has accumulated massive bioprocessing development data from its 3100 m2 CMC facility and has successfully brought a number of biologic products to NDA stage. The company has created an intelligent centralized database where deep learning is being performed to create a next-generation, all-encompassing AI-enabled bioprocessing ecosystem. Great Bay Bio is headquartered in China and was founded in 2019 by Kingsley Leung and Michael Chen, who has been the CEO since incorporation. | Founder | - |
Eerdere bekende functies van Kingsley Leung
Bedrijven | Functie | Einde |
---|---|---|
Young Innovation & Development Alliance | Corporate Officer/Principal | - |
Federation of Hong Kong Industries | Corporate Officer/Principal | - |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Corporate Officer/Principal | - |
Opleiding van Kingsley Leung
University of Oxford | Graduate Degree |
Imperial College London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UNI-BIO SCIENCE GROUP LIMITED | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
The Hong Kong Institute of Directors
The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Commercial Services |
Federation of Hong Kong Industries | |
The Hong Kong Society of Financial Analysts | |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Greater Bay Capital Ltd.
Greater Bay Capital Ltd. Financial ConglomeratesFinance Greater Bay Capital Ltd. operates as an investment holding company. The company is headquartered in British Virgin Islands. | Finance |
Young Innovation & Development Alliance | |
Great Bay Bio Holdings Ltd.
Great Bay Bio Holdings Ltd. Packaged SoftwareTechnology Services Great Bay Bio Holdings Ltd. is a high-tech enterprise based in China that specializes in applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing. The Chinese company aims to solve numerous pain-points of the biopharmaceutical industry, including high failure rates, long development timelines, and high costs. Great Bay Bio has accumulated massive bioprocessing development data from its 3100 m2 CMC facility and has successfully brought a number of biologic products to NDA stage. The company has created an intelligent centralized database where deep learning is being performed to create a next-generation, all-encompassing AI-enabled bioprocessing ecosystem. Great Bay Bio is headquartered in China and was founded in 2019 by Kingsley Leung and Michael Chen, who has been the CEO since incorporation. | Technology Services |